rdf:type |
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0003873,
umls-concept:C0030705,
umls-concept:C0031327,
umls-concept:C0039099,
umls-concept:C0086418,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0393022,
umls-concept:C0871261,
umls-concept:C1527148,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-1-28
|
pubmed:abstractText |
To analyse whether persistence of synovial B lineage cells and lack of clinical response to rituximab treatment in patients with rheumatoid arthritis (RA) are associated with low rituximab serum levels and anti-rituximab antibody (ARA) formation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1468-2060
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
409-12
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19596693-Antibodies, Anti-Idiotypic,
pubmed-meshheading:19596693-Antibodies, Monoclonal,
pubmed-meshheading:19596693-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:19596693-Arthritis, Rheumatoid,
pubmed-meshheading:19596693-B-Lymphocyte Subsets,
pubmed-meshheading:19596693-Cohort Studies,
pubmed-meshheading:19596693-Female,
pubmed-meshheading:19596693-Humans,
pubmed-meshheading:19596693-Male,
pubmed-meshheading:19596693-Severity of Illness Index,
pubmed-meshheading:19596693-Synovial Membrane,
pubmed-meshheading:19596693-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
|
pubmed:affiliation |
Academic Medical Centre/University of Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|